Court dismisses Bristol Myers Squibb, J&J challenges to Medicare drug price negotiations, rejecting unconstitutionality claims

STAT@statnews

1 year ago

Federal judge rules against two drugmakers challenging Medicare drug price negotiation program. https://t.co/9UJC7q3lgp

Healthcare and drugmaker groups sought to revive a challenge to US drug-pricing law. The groups sued the government last year, claiming the program, a signature initiative of Biden, violated the Constitution https://t.co/WEusP1Rlvi https://t.co/6ACgrFuPxr

Healthcare and drug industry groups urged a U.S. appeals court to revive their challenge to a law requiring manufacturers to negotiate the prices of some drugs with the U.S government's Medicare health insurance program or pay heavy penalties @brenpiers https://t.co/WEusP1QNFK https://t.co/jmPzfJSfXc